Trial intelligence / Profile preview

Bioequivalence study of linagliptin 5 mg film-coated tablets vs Trajenta 5 mg in healthy Thai adults under fasting

TCTR20221212003Phase 1Unknown

Sponsor
Mylan
Start
Mar 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised trial of linagliptin (2 arms), sponsored by Mylan. Status: unknown.

02

Drugs

linagliptin

Beyond the preview

Go deeper on TCTR20221212003.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20221212003.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call